16-138183-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_001077350.3(NPRL3):c.85C>A(p.Gln29Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000659 in 151,842 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001077350.3 missense
Scores
Clinical Significance
Conservation
Publications
- focal epilepsyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- epilepsy, familial focal, with variable foci 3Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- familial focal epilepsy with variable fociInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001077350.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NPRL3 | NM_001077350.3 | MANE Select | c.85C>A | p.Gln29Lys | missense | Exon 2 of 14 | NP_001070818.1 | ||
| NPRL3 | NM_001243248.2 | c.85C>A | p.Gln29Lys | missense | Exon 2 of 13 | NP_001230177.1 | |||
| NPRL3 | NM_001243249.2 | c.85C>A | p.Gln29Lys | missense | Exon 1 of 12 | NP_001230178.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NPRL3 | ENST00000611875.5 | TSL:5 MANE Select | c.85C>A | p.Gln29Lys | missense | Exon 2 of 14 | ENSP00000478273.1 | ||
| NPRL3 | ENST00000399953.7 | TSL:1 | c.85C>A | p.Gln29Lys | missense | Exon 1 of 12 | ENSP00000382834.4 | ||
| NPRL3 | ENST00000621703.4 | TSL:1 | n.85C>A | non_coding_transcript_exon | Exon 1 of 11 | ENSP00000477801.1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151842Hom.: 0 Cov.: 30 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1457362Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 724468
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151842Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 74114 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Epilepsy, familial focal, with variable foci 3 Uncertain:1
This sequence change replaces glutamine, which is neutral and polar, with lysine, which is basic and polar, at codon 29 of the NPRL3 protein (p.Gln29Lys). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with NPRL3-related conditions. ClinVar contains an entry for this variant (Variation ID: 568625). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt NPRL3 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at